local_hospital

Centrul de Kinetoterapie si Masaj Banat SRL

Address
Strada Elisabeta Rizea nr. 5, SAD B2, SAD B3, SAD B4, parter, 300778 Timișoara, Romania

Centrul de Kinetoterapie si Masaj Banat SRL - Rheumatology and Autoimmune Disease Research

Centrul de Kinetoterapie si Masaj Banat SRL is a specialized clinical research facility focused on evaluating innovative therapeutic interventions for complex autoimmune and rheumatologic conditions. The center combines expertise in physical therapy and rehabilitation with advanced clinical trial capabilities to assess novel pharmacological treatments for inflammatory diseases.

  • Psoriatic arthritis treatment development and biologic disease-modifying therapies
  • Systemic lupus erythematosus therapeutic interventions and disease activity monitoring
  • Autoimmune rheumatic disease management and emerging immunomodulatory agents

The center's research portfolio demonstrates particular strength in conducting placebo-controlled efficacy and safety studies for biologic-naïve patients with active psoriatic arthritis and participants with active systemic lupus erythematosus. Their experience with standardized disease activity indices such as the SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) and comprehensive assessment protocols positions them as a valuable contributor to the development of next-generation therapies for challenging autoimmune conditions.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
2
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
0
Sponsors (total)
2
Active sponsors
0

Sponsor Network

Top 10 by active trials.

No sponsors linked to active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 442 other sites in Romania

description
Trial volume
2
Outperforms 37% of sites
public
Therapeutic diversity
1areas
Outperforms 2% of sites
groups
Sponsor diversity
2sponsors
Outperforms 42% of sites

Therapeutic Area Benchmark — Romania

Select a therapeutic area to compare against other sites in Romania.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Romania

Market Share

Country: Romania

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centrul de Kinetoterapie si Masaj Banat SRL

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Efficacy and Safety Evaluation of Deucravacitinib in Biologic-Naïve Patients with Active Psoriatic Arthritis: A Phase 3 Randomized, Double-Blind, Placebo-Controlled StudyBristol-Myers Squibb Services Unlimited CompanyPhase IIINot RecruitingOct 2021

IMP list

lock Showing 1 of 2 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Afimetoran Besilate Dihydrate1Unknown2021-11-252021-11-25

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.